Piper Sandler Reiterates Overweight on Omega Therapeutics, Lowers Price Target to $9

Omega Therapeutics -4.17%

Omega Therapeutics

OMGA

2.41

-4.17%

Piper Sandler analyst Edward Tenthoff reiterates Omega Therapeutics (NASDAQ: OMGA) with a Overweight and lowers the price target from $10 to $9.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via